Moreover, we identify a novel signaling axis through which NMS may downregulate HTR1D expression and subsequently inhibits the cAMP/PKA/IκBα/NF-κB pathway, ultimately suppressing tumor proliferation and promoting apoptosis. The gene discussed is HTR1D; the disease is neoplasm.